Bluemoon is a modern hybrid strain created through the crossing of three distinct genetic contributors: an unknown strain, Blue Elite Indica, and Mota Khan Afghana. As a mid-cycle flowering variety requiring moderate cultivation skill, it is suited for both indoor and outdoor environments and produces high yields within its sixty-three-day flowering window. This specific lineage served as the foundation for the notable offspring known as Blue Moon Rocks, solidifying its place in contemporary breeding programs.

The chemical profile of Bluemoon is defined by a complex, multi-tiered terpene arrangement dominated by myrcene, followed by secondary and tertiary contributions from pinene, caryophyllene, ocimene, and limonene. Additional aromatic nuance is provided by the presence of beta-pinene, linalool, humulene, nerolidol, guaiol, bisabolol, p-cymene, and camphene. This broad spectrum of terpenes interacts to shape the strain’s sensory experience, reflecting a diverse profile that spans from earthy and herbaceous notes to sharper, woodier undercurrents.

As a THC-dominant variety, Bluemoon is cultivated primarily for its ability to induce effects that are consistently relaxed, happy, and uplifted. These therapeutic outcomes make it a frequent choice for individuals seeking relief from stress and physical pain, as well as those looking for support with sleep patterns. By balancing elevated potency with its specific terpene-driven effects, the strain remains a functional selection for both daily management and evening use.